The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Open accessAbstract
Exhausted CD8+ T (T ex) cells in chronic infections and cancer have limited effector function, high co-expression of inhibitory receptors and extensive transcriptional changes compared with effector (T eff) or memory (T mem) CD8+ T cells. T ex cells are important clinical targets of checkpoint blockade and other immunotherapies. Epigenetically, T ex cells are a distinct immune subset, with a unique chromatin landscape compared with T eff and T mem cells. However, the mechanisms that govern the transcriptional and epigenetic development of T ex cells remain unknown. Here we identify the HMG-box transcription factor TOX as a central regulator of T ex cells in mice. TOX is largely dispensable for the formation of T eff and T mem cells, but it is critical for exhaustion: in the absence of TOX, T ex cells do not form. TOX is induced by calcineurin and NFAT2, and operates in a feed-forward loop in which it becomes calcineurin-independent and sustained in T ex cells. Robust expression of TOX therefore results in commitment to T ex cells by translating persistent stimulation into a distinct T ex cell transcriptional and epigenetic developmental program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“which transcriptionally and epigenetically programs CD8+ T cell exhaustion [52].”
From Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC (2025) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“Treatment‐induced declines in PD‐1+ CD8 T cells are consistent with the possibility that thymus regeneration treatment epigenetically reprograms “exhausted” CD8 T cells (T EX), a recently characterized distinct PD‐1+ CD8 population (Khan et al., 2019).”
From Reversal of epigenetic aging and immunosenescent trends in humans. (2019) · cites this paper as Khan et al., 2019
In the citing paper
“The excessive antigen density and kinetics of antigen exposure in solid tumors can drive exhaustion or dysfunction of T cells (Khan et al., 2019; Wherry, 2011).”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Khan et al., 2019
In the citing paper
“Furthermore, bulk RNA-seq analysis of isolated cells (ND naïve, HFHC Tem, HFHC Trm, and RES Trm) revealed that both Trm subsets from HFHC mice and RES mice expressed core signature genes of Trm21–24 with exceptions including Itgae (CD103) and Eomes (Fig. 4d).”
From CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells (2021) · cites this paper as [24]
In the citing paper
“CD8 T cells are typically regarded as a uniform population with cytotoxic function; however, recent studies have highlighted the diversity of the CD8 T-cell population (5)(6)(7)(8)(9).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Self-citationMaster Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationSuper-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Cited by
Sorted by citations
Items 301–400 of 1,001
Impact of epigenetic reprogramming on antitumor immune responses in glioma
McClellan, B. L., Haase, S., Núñez, F. J., Alghamri, M. S., Dabaja, A. A., Lowenstein, P. R., & Castro, M. G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163450 · Cited by 68
FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells
Zhu, Z., Lou, G., Teng, X.-L., Wang, H., Luo, Y., Shi, W., Yihunie, K. D., Hao, S., DeGolier, K., Liao, C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01685-w · Cited by 69
Distinct epigenomic landscapes underlie tissue-specific memory T cell differentiation
Buquicchio, F. A., Fonseca, R., Yan, P., Wang, F., Evrard, M., Obers, A., Gutierrez, J. C., Raposo, C. J., Belk, J. A., Dániel, B., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.06.014 · Cited by 65
Self-citationEpigenetic Regulation of T Cell Memory: Recalling Therapeutic Implications
Tough, D. F., Rioja, I., Modis, L. K., & Prinjha, R. K. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.11.008 · Cited by 67
Exposing Hidden Targets: Combining epigenetic and immunotherapy to overcome cancer resistance
Olino, K. L., Park, T. S., & Ahuja, N. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.001 · Cited by 65
Mechanisms of T cell exhaustion guiding next-generation immunotherapy
Zebley, C. C., & Youngblood, B. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.04.004 · Cited by 65
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
Zhong, M., Gao, R., Zhao, R., Huang, Y., Chen, C., Li, K., Yu, X., Nie, D., Chen, Z., Liu, X., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05123-x · Cited by 64
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
Smole, A., Benton, A., Poussin, M., Eiva, M. A., Mezzanotte, C., Camisa, B., Greco, B. M., Sharma, P., Minutolo, N. G., Gray, F., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.11.006 · Cited by 72
Liu, Z. Z., Li, X., Gao, Y., Liu, J., Feng, Y.-T., Yang, L., Wang, J., Wang, C., Wang, D., He, J., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01768-0 · Cited by 67
Ahn, T., Bae, E., & Seo, H. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.004 · Cited by 71
TOX as a potential target for immunotherapy in lymphocytic malignancies
Liang, C., Huang, S., Zhao, Y., Chen, S., & Li, Y. (2021) · Biomarker Research · doi:10.1186/s40364-021-00275-y · Cited by 66
Chan, S., Belmar, N. A., Ho, S., Rogers, B. M., Stickler, M. M., Graham, M., Lee, E., Tran, N., Zhang, D., Gupta, P., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00334-9 · Cited by 67
Wang, W., Zhang, Y., Zhang, X., Li, C., Yuan, L., Zhang, D., Zhao, Y., Li, X., Cheng, J., Lin, C., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01642-7 · Cited by 73
Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
Verdeil, G., Lawrence, T., Schmitt‐Verhulst, A., & Auphan‐Anezin, N. (2019) · Cancers · doi:10.3390/cancers11121832 · Cited by 64
Hu, H., Zakharov, P. N., Peterson, O. J., & Unanue, E. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019743117 · Cited by 63
Sherafat, N. S., Keshavarz, A., Mardi, A., Mohammadiara, A., Aghaei, M., Maleki, L. A., & Mohammadi, M. H. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01751-7 · Cited by 67
Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion
Wu, Y., Wu, Y., Gao, Z., Yu, W., Zhang, L., & Zhou, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02327-3 · Cited by 78
Fujiwara, Y., Mittra, A., Naqash, A. R., & Takebe, N. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.11 · Cited by 67
Lee, Y. J., Kim, J. Y., Jeon, S. H., Nam, H., Jung, J. H., Jeon, M., Kim, E.-S., Bae, S. J., Ahn, J., Yoo, T.-K., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abn8390 · Cited by 56
Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
Alahdal, M., & Elkord, E. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109177 · Cited by 60
Exhausted CD8+ T cells face a developmental fork in the road
Zander, R., & Cui, W. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.02.006 · Cited by 65
Tremain, A. C., Wallace, R. P., Lorentz, K. M., Thornley, T. B., Antane, J. T., Raczy, M. M., Reda, J. W., Alpar, A. T., Slezak, A. J., Watkins, E. A., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01086-2 · Cited by 61
Prospects and challenges of CAR-T cell therapy combined with ICIs
Lv, Y., Luo, X., Xie, Z., Qiu, J.-Y., Yang, J., Deng, Y., Long, R., Tang, G., Zhang, C., & Zuo, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1368732 · Cited by 62
Minnie, S. A., Waltner, O. G., Zhang, P., Takahashi, S., Nemychenkov, N. S., Ensbey, K. S., Schmidt, C. R., Legg, S. R. W., Comstock, M., Boiko, J. R., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adg1094 · Cited by 58
Layilin augments integrin activation to promote antitumor immunity
Mahuron, K. M., Moreau, J. M., Glasgow, J. E., Boda, D. P., Pauli, M. L., Gouirand, V., Panjabi, L., Grewal, R., Luber, J. M., Mathur, A. N., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192080 · Cited by 60
Höllbacher, B., Duhen, T. M., Motley, S., Klicznik, M. M., Gratz, I. K., & Campbell, D. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000037 · Cited by 60
CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape
Chen, Y., Xu, J., Wu, X., Yao, H., Yan, Z., Guo, T., Wang, W., Wang, P., Li, Y., Yang, X.-M., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00570-y · Cited by 60
Wu, M., Xia, X., Hu, J., Fowlkes, N. W., & Li, S. (2021) · Nature Communications · doi:10.1038/s41467-021-23864-9 · Cited by 61
Bashash, D., Zandi, Z., Kashani, B., Pourbagheri‐Sigaroodi, A., Salari, S., & Ghaffari, S. H. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30575 · Cited by 62
Zheng, P., Dou, Y., & Wang, Q.-Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1206720 · Cited by 54
Sandu, I., Cerletti, D., Claassen, M., & Oxenius, A. (2020) · Nature Communications · doi:10.1038/s41467-020-18256-4 · Cited by 60
Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance
Wagle, M. V., Vervoort, S. J., Kelly, M. J., Byl, W. V. D., Peters, T. J., Martin, B. P., Martelotto, L. G., Nüssing, S., Ramsbottom, K. M., Torpy, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23044-9 · Cited by 62
Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies
Ta, T. M., Malik, S., Anderson, E. M., Jones, A. D., Perchik, J., Freylikh, M., Sardo, L., Klase, Z. A., & Izumi, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.862270 · Cited by 61
Jaiswal, A., Verma, A., Dannenfelser, R., Melssen, M. M., Tirosh, I., Izar, B., Kim, T., Nirschl, C. J., Devi, K. S. P., Olson, W. C., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.005 · Cited by 61
Zhang, Y., Hu, J., Ji, K., Jiang, S., Dong, Y., Sun, L., Wang, J., Hu, G., Chen, D., Chen, K., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101151 · Cited by 63
Glutarate regulates T cell metabolism and anti-tumour immunity
Minogue, E., Cunha, P. P., Wadsworth, B. J., Grice, G. L., Sah‐Teli, S. K., Hughes, R. J. F., Bargiela, D., Quaranta, A., Zurita, J., Antrobus, R., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00855-2 · Cited by 60
Zhou, Z., Wang, J., Wang, J., Yang, S., Wang, R., Zhang, G., Li, Z., Shi, R., Wang, Z., & Lu, Q. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02047-2 · Cited by 66
Metabolic Control of Epigenetics and Its Role in CD8+ T Cell Differentiation and Function
Yerinde, C., Siegmund, B., Glauben, R., & Weidinger, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02718 · Cited by 61
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
Bachireddy, P., Azizi, E., Burdziak, C., Nguyen, V. N., Ennis, C. S., Maurer, K., Park, C. Y., Choo, Z.-N., Li, S., Gohil, S. H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109992 · Cited by 55
The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy
Micevic, G., Bosenberg, M., & Yan, Q. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0784 · Cited by 60
Huang, Y., Shao, M., Teng, X., Si, X., Wu, L., Jiang, P., Liu, L., Cai, B., Wang, X., Han, Y., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101400 · Cited by 63
Almawash, S. (2025) · Cancers · doi:10.3390/cancers17050880 · Cited by 69
Takata, H., Mitchell, J. L., Pacheco, J. A., Pagliuzza, A., Pinyakorn, S., Buranapraditkun, S., Sacdalan, C., Leyre, L., Nathanson, S., Kakazu, J. C., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.012 · Cited by 58
Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting
Aggen, D. H., Drake, C. G., & Rini, B. I. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3323 · Cited by 57
Xydia, M., Rahbari, R., Ruggiero, E., Macaulay, I. C., Tarabichi, M., Lohmayer, R., Wilkening, S., Michels, T., Brown, D. V., Vanuytven, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21297-y · Cited by 59
The tumor microenvironment shapes the molecular characteristics of exhausted CD8+ T cells
Cheng, H., Ma, K., Zhang, L., & Li, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.013 · Cited by 60
Sivakumar, S., Abu‐Shah, E., Ahern, D., Arbe-Barnes, E. H., Jainarayanan, A., Mangal, N., Reddy, S., Rendek, A., Easton, A., Kurz, E., et al. (2021) · Cancers · doi:10.3390/cancers13081776 · Cited by 48
Knowns and Unknowns about CAR-T Cell Dysfunction
Titov, A., Kaminskiy, Y., Ganeeva, I., Zmievskaya, E., Valiullina, A., Rakhmatullina, A., Petukhov, A., Рифкатовна, М. Р., Rizvanov, A. A., & Bulatov, E. (2022) · Cancers · doi:10.3390/cancers14041078 · Cited by 56
Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement
Lan, X., Tian, M., Alli, S., Guy, C. S., Djekidel, M. N., Liu, X., Boi, S. K., Chowdhury, P. S., He, M.-H., Zehn, D., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01843-8 · Cited by 59
Rausch, L., & Kallies, A. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082223-044122 · Cited by 66
Heterogeneity of HBV-Specific CD8+ T-Cell Failure: Implications for Immunotherapy
Heim, K., Neumann‐Haefelin, C., Thimme, R., & Hofmann, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02240 · Cited by 56
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
Im, S. J., & Ha, S. (2020) · Immune Network · doi:10.4110/in.2020.20.e2 · Cited by 58
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma
Kourtis, N., Wang, Q., Wang, B., Oswald, E. M., Adler, C., Cherravuru, S., Malahias, E., Zhang, L., Golubov, J., Wei, Q., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00391-0 · Cited by 55
Wu, P., Zhang, H., Sun, M., Mao, S., He, Q., Shi, Y., Deng, Y., Dong, Z., Xu, Q., Zhao, C., et al. (2022) · Advanced Materials · doi:10.1002/adma.202203019 · Cited by 56
Koh, J., Kim, S., Woo, Y. D., Song, S. G., Yim, J., Han, B., Lim, S., Ahn, H. K., Mun, S., Kim, J. S., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.07.004 · Cited by 57
Harnessing CD8 T cell responses using PD-1–IL-2 combination therapy
Hashimoto, M., Ramalingam, S. S., & Ahmed, R. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.11.008 · Cited by 57
Priming and Maintenance of Adaptive Immunity in the Liver
Kawashima, K., Andreata, F., Beccaría, C. G., & Iannacone, M. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090122-041354 · Cited by 56
Roessner, P. M., Cid, L. L., Lupar, E., Roider, T., Bordas, M., Schifflers, C., Arseni, L., Gaupel, A., Kilpert, F., Krötschel, M., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01136-1 · Cited by 59
Extracellular signal-regulated kinase (ERK) pathway control of CD8+ T cell differentiation
Damasio, M. P. S., Marchingo, J. M., Spinelli, L., Hukelmann, J. L., Cantrell, D. A., & Howden, A. J. M. (2020) · Biochemical Journal · doi:10.1042/bcj20200661 · Cited by 56
CD8+ T Cell Responses during HCV Infection and HCC
Hofmann, M., Tauber, C., Hensel, N., & Thimme, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050991 · Cited by 58
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet
Zhao, S., Peralta, R. M., Avina-Ochoa, N., Delgoffe, G. M., & Kaech, S. M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101485 · Cited by 58
Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
Jindal, S., Pennock, N. D., Sun, D., Horton, W. R., Ozaki, M. K., Narasimhan, J., Bartlett, A. Q., Weinmann, S. A., Goss, P. E., Borges, V. F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26505-3 · Cited by 55
Kim, C. G., Kim, G., Kim, K. H., Park, S., Shin, S., Yeo, D., Shim, H. S., Yoon, H. I., Park, S. Y., Ha, S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002780 · Cited by 57
Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy
Veliça, P., Cunha, P. P., Vojnovic, N., Foskolou, I. P., Bargiela, D., Gojkovic, M., Rundqvist, H., & Johnson, R. S. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0561 · Cited by 52
“297 Notably, HIF-2ɑ decreased expression of transcription factors associated with 298 naive/memory as well as the exhausted state (Tcf7 (28,29), Tox (30), Nr4a1, Nr4a3 299 (31) and Eomes (32)).”
BackgroundSingle-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
Gibellini, L., Biasi, S. D., Porta, C., Tartaro, D. L., Depenni, R., Pellacani, G., Sabbatini, R., & Cossarizza, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00490 · Cited by 55
Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion
Busselaar, J., Tian, S., van Eenennaam, H., & Borst, J. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.592569 · Cited by 57
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors
Zhang, H., Yu, P., Tomar, V. S., Chen, X., Atherton, M. J., Lu, Z. F., Zhang, H.-G., Li, S., Ortiz, A., Gui, J., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00383-0 · Cited by 57
Self-citationRgs16 promotes antitumor CD8 + T cell exhaustion
Weisshaar, N., Wu, J., Ming, Y., Madi, A., Hotz‐Wagenblatt, A., Ma, S., Mieg, A., Hering, M., Zettl, F., Möhr, K., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abh1873 · Cited by 54
Self-citationTechnology meets TILs: Deciphering T cell function in the -omics era
Hudson, W. H., & Wieland, A. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.09.011 · Cited by 55
Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment
Guan, Q., Han, M., Guo, Q., Yan, F., Wang, M., Ning, Q., & Xi, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1204363 · Cited by 57
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control
Bréart, B., Williams, K., Krimm, S., Wong, T., Kayser, B. D., Wang, L., Cheng, E., Tleugabulova, M. C., Bouziat, R., Lu, T., et al. (2025) · Nature · doi:10.1038/s41586-024-08510-w · Cited by 55
Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
Huang, Y., Ngiow, S. F., Baxter, A. E., Manne, S., Park, S. L., Wu, J. E., Khan, O., Giles, J. R., & Wherry, E. J. (2025) · Science Immunology · doi:10.1126/sciimmunol.ado3032 · Cited by 57
Self-citationChen, S., Wang, Y., Dang, J., Song, N., Chen, X., Wang, J., Huang, G. N., Brown, C. E., Yu, J., Weissman, I. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59326-9 · Cited by 60
Chen, J., Yang, J., Li, H., Yang, Z., Zhang, X., Li, X., Wang, J., Zhang, Y., Chen, S., & Song, M. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12910 · Cited by 57
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Schmiechen, Z. C., & Stromnes, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613815 · Cited by 56
Marotel, M., Villard, M., Drouillard, A., Tout, I., Besson, L., Allatif, O., Pujol, M., Rocca, Y., Ainouze, M., Roblot, G., et al. (2021) · eLife · doi:10.7554/elife.60095 · Cited by 54
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
Roy, D., Gilmour, C., Patnaik, S., & Wang, L. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1264327 · Cited by 53
Chen, Q., Li, Y., Wang, X., Zhang, X., Hu, Y., Li, L., Suo, D., Ni, K., Li, Z., Zhan, J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1542 · Cited by 55
Epigenetic regulation of natural killer cell memory*
Lau, C. M., Wiedemann, G. M., & Sun, J. C.-Y. (2021) · Immunological Reviews · doi:10.1111/imr.13031 · Cited by 55
Sacirbegovic, F., Günther, M., Greco, A., Zhao, D., Wang, X., Zhou, M., Rosenberger, S., Oberbarnscheidt, M. H., Held, W., McNiff, J. M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.003 · Cited by 54
Shi, T., Burg, A. R., Caldwell, J. T., Roskin, K. M., Castro-Rojas, C. M., Chukwuma, P. C., Gray, G. I., Foote, S. G., Alonso, J. A., Cuda, C. M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170191 · Cited by 54
A spatial sequencing atlas of age-induced changes in the lung during influenza infection
Kasmani, M. Y., Topchyan, P., Brown, A. K., Brown, R. J., Wu, X., Chen, Y., Khatun, A., Alson, D., Wu, Y., Burns, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42021-y · Cited by 55
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control
Weiss, S. A., Huang, A. Y., Fung, M. E., Martínez, D., Chen, C.-Y., LaSalle, T. J., Miller, B. C., Scharer, C. D., Hegde, M., Nguyen, T. H., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01961-3 · Cited by 56
Self-citationXu, Y., Wu, G., Li, J., Li, J., Ruan, N., Ma, L., Han, X., Wei, Y., Li, L., Zhang, H., et al. (2020) · BioMed Research International · doi:10.1155/2020/8283401 · Cited by 52
Therapeutic potential of co-signaling receptor modulation in hepatitis B
Andreata, F., Laura, C., Ravà, M., Krueger, C. C., Ficht, X., Kawashima, K., Beccaría, C. G., Moalli, F., Partini, B., Fumagalli, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.038 · Cited by 54
Mitochondrial respiration is necessary for CD8+ T cell proliferation and cell fate
Steinert, E. M., Bruza, B. F., Danchine, V. D., Grant, R. A., Vasan, K., Kharel, A., Zhang, Y., Cui, W., Szibor, M., Weinberg, S. E., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02202-x · Cited by 56
Use of Mass Cytometry to Profile Human T Cell Exhaustion
Winkler, F., & Bengsch, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03039 · Cited by 54
Self-citationTOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma
Guo, L., Li, X., Liu, R., Chen, Y., Ren, C., & Du, S. (2020) · Cancer Medicine · doi:10.1002/cam4.3324 · Cited by 50
Wu, P., Zhang, H., Yin, Y., Sun, M., Mao, S., Chen, H., Deng, Y., Chen, S., Li, S., & Sun, B. (2022) · Advanced Science · doi:10.1002/advs.202105894 · Cited by 50
T cell exhaustion is associated with antigen abundance and promotes transplant acceptance
Zou, D., Dai, Y., Zhang, X., Wang, G., Xiao, X., Jia, P., Li, X. C., Guo, Z., & Chen, W. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15870 · Cited by 49
Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
Tien, F., Lu, H., Lin, S., & Tsai, H.-C. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-022-00893-0 · Cited by 51
Nutsch, K., Banta, K. L., Wu, T. D., Tran, C. W., Mittman, S., Duong, E., Nabet, B. Y., Qu, Y., Williams, K., Müller, S., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00870-6 · Cited by 57
Targeting metabolism to reverse T‐cell exhaustion in chronic viral infections
Sears, J. D., Waldron, K. J., Wei, J. N., & Chang, C. (2020) · Immunology · doi:10.1111/imm.13238 · Cited by 51
EZH2 as a Regulator of CD8+ T Cell Fate and Function
Stairiker, C. J., Thomas, G. D., & Salek‐Ardakani, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.593203 · Cited by 49
Immunometabolism in the Tumor Microenvironment
Roy, D. G., Kaymak, I., Williams, K. S., Ma, E. H., & Jones, R. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055817 · Cited by 49
Jiang, P., Zhang, Z., Hu, Y., Liang, Z., Han, Y., Li, X., Zeng, X., Zhang, H., Zhu, M., Dong, J. W., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01676-0 · Cited by 49
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma
Tomaszewski, W. H., Polania, J. W., Chakraborty, M. A., Perera, J., Ratiu, J. J., Hoyt-Miggelbrink, A. M., McDonnell, D. P., Khasraw, M., Ashley, D. M., Fecci, P. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34175-y · Cited by 48
The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders
Terrabuio, E., Zenaro, E., & Constantin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1233870 · Cited by 51
The role of CD4+ T cells in tumor and chronic viral immune responses
Xie, L., Fang, J., Yu, J., Zhang, W., He, Z., Ye, L., & Wang, H. (2023) · MedComm · doi:10.1002/mco2.390 · Cited by 54
Mfsd2a: A Physiologically Important Lysolipid Transporter in the Brain and Eye
Wong, B. H., & Silver, D. L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_14 · Cited by 49
Metadata
- Authors
- Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., Attanasio, J., Yan, P., George, S. M., Bengsch, B., Staupe, R. P., Donahue, G., Xu, W., Amaravadi, R. K., Xu, X., Karakousis, G. C., Mitchell, T. C., Schuchter, L. M., Kaye, J., Berger, S. L., & Wherry, E. J.
- Affiliations
- Arsenal Biosciences (United States) (US)
- University of Pennsylvania (US)
- University of Freiburg (DE)
- Abramson Cancer Center (US)
- Cedars-Sinai Medical Center (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Wherry, E. John
- ORCID
- Khan, Omar
- Giles, Josephine R.
- McDonald, Sierra
- Manne, Sasikanth
- Ngiow, Shin Foong
- Patel, Kunal P.
- Werner, Michael T.
- Huang, Alexander C.
- Alexander, Katherine A.
- Wu, Jennifer E.
- Attanasio, John
- Yan, Patrick
- Bengsch, Bertram
- Staupe, Ryan P.
- Donahue, Greg
- Xu, Wei
- Amaravadi, Ravi K.
- Xu, Xiaowei
- Karakousis, Giorgos C.
- Mitchell, Tara C.
- Schuchter, Lynn M.
- Kaye, Jonathan
- Berger, Shelley L.
- Wherry, E. John
- Venue
- Nature
- Published
- 2019-06-17
- Volume
- 571
- Issue
- 7764
- Pages
- 211-218
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6713202
- OpenAlex
- W2952815301
- Cited by
- 1,646
- References
- 63
- Citations by year
- 2026: 258 · 2025: 249 · 2024: 234 · 2023: 252 · 2022: 211 · 2021: 235 · 2020: 161 · 2019: 43
- FWCI
- 64.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA078831, F32CA221010, P30CA010815, P01CA210944)
- National Institute of Allergy and Infectious Diseases (R01AI115712, R01AI054977, R01AI105343, F30AI129263, U19AI117950, U19AI082630, P01AI108545)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- TOX transcription factor, CD8+ T cell exhaustion, chromatin landscape, epigenetic regulation, calcineurin, NFATc1, feed-forward loop, inhibitory receptors, chronic infection, cancer immunotherapy, checkpoint blockade, transcriptional programs
- MeSH terms
- Animals, Epistasis, Genetic, Female, Gene Expression Regulation, Genotype, Immunologic Memory, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Transcription, Genetic, Homeodomain Proteins, CD8-Positive T-Lymphocytes, Tumor Escape, Calcineurin, Calcium Signaling, Feedback, Physiological, NFATC Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
